Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04077047 · ClinicalTrials.gov registry record · NA

Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04077047 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04077047, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS) is the second leading cause of death in Africa. Adolescents living with HIV (ALWH) are at increased risk for HIV-related morbidity and mortality due to poor retention in HIV care and suboptimal antiretroviral therapy (ART) adherence. Despite having the world's largest population of Adolescents living with HIV (ALWH) (15-24 years, n=870,000), only 14% of South African ALWH are on ART, 12% are retained in HIV care 1-2 years after ART initiation, and 10% are virally suppressed. During treatment interruption, the effects of ART quickly reverse, increasing transmission risk, treatment resistance, and potentially fatal complications. Unless their treatment retention and adherence improves, ALWH will continue to transmit the virus to their sexual partners and die prematurely. While social support is often viewed as a bridge that joins ALWH to key resources within their environments, little is known about which types of social support are most impactful and from whom within their network, particularly among ALWH in endemic countries. Moreover, many South African ALWH lack social support from key social network members due to lack of HIV status disclosure, increasing their risk for poorer HIV-related outcomes when compare to their disclosed peers. Social network interventions (i.e., those that leverage the resources within one's network to improve behaviors and outcomes) that meet the needs of both ALWH who are disclosed and non-disclosed are needed, but lacking. Such inventions have the potential to facilitate appraisal support, during which ALWH receive targeted assistance with identifying appropriate and trustworthy people in their lives. More broadly, there exists a lack empirically supported interventions aimed at improving retention in HIV care and ART adherence for ALWH in low-middle income countries. This proposal follows the multiphase optimization strategy (MOST), a comprehensive framewo

Interventions

  • BEHAVIORAL iEngage

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-09-01
Est. Completion 2025-07-31
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04077047

The ClinicalTrials.gov registry entry for NCT04077047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which iEngage is the first listed.

NCT04077047 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04077047 about?

NCT04077047 is a clinical study titled "Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention". human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS) is the second leading cause of death in Africa. Adolescents living with HIV (ALWH) are at increased risk for HIV-related morbidity and mortality due to poor retention in HIV care and suboptimal antiretroviral therapy (ART) ...

What is the current status of trial NCT04077047?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-09-01. Estimated completion is 2025-07-31.

What interventions are being tested in trial NCT04077047?

The interventions under investigation include: iEngage (BEHAVIORAL).

Who is sponsoring clinical trial NCT04077047?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.